Geeta Lal, MD, MSc


Associate Professor of Surgery
Endocrine and Breast Oncology Surgeon
Co-Director, 4JPP, Medical/Surgical Oncology Inpatient Unit
Co-Leader of Endocrine MOG
Associate Professor of Surgery  - Surgical Oncology and Endocrine Surgery

Contact Information

Primary Office: 4641 JCP
Iowa City, IA 52242
Phone: 319-356-1327

Web: Geeta Lal Surgical Oncology Laboratory


BS, Summa cum Laude, McMaster University
MD, Honors, University of Toronto
MSc, University of Toronto and The Samuel Lunenfeld Research Institute

Residency, General Surgery, University of Toronto
Fellowship, Endocrine Surgical Oncology, Mt. Zion Medical Center, University of California, San Francisco

Licensure and Certifications

Board Certified, General Surgery, American Board of Surgery
Iowa Medical License, Iowa Board of Medical Examiners
Royal College of Physicians and Surgeons of Canada

Research Summary

Geeta Lal Surgical Oncology Laboratory-

All Publications

Bhama A, Lal G.  Autoimmune rheumatic disease (polymyositis & dermatomyositis) associated with papillary thyroid carcinoma: Case series and review of the literature.  World Journal of Endocrine Surgery.  2013. 

Lal G, Clark O.  Thyroid, Parathyroid and Adrenal.  2013. 

Khullar p, Lal G.  Hyperthyroidism, thyroiditis and non-toxic goiter.  2012. 

O’Malley Y, Lal G, Howe J, Weigel R, Sugg S.  Invasion in follicular thyroid cancer (FTC) cell lines is mediated by EphA2 and p-Akt.  Surgery.  2012. 152(6):1218-24.

Lal G, Groff  M, Howe  J, Weigel  , Sugg  S, Lynch  C.  Risk of second primary thyroid cancer following another malignancy: Trends in a population-based study.  Ann Surg Oncol .  2012 January. 

Lal G, Spanheimer  P, Sugg  S, Howe  J, Weigel  R.  Surveillance and intervention following thyroid lobectomy.  Ann Surg Oncol .  2011 June. 18(6):1729-33.

Lal G, Fang  S.  Parathyroid cancer.  Endocr Pract.  2011 April. 1:36-43.

Lal G, Weigel  R, Kirby  P, Miron  , Royer  N.  Incidental finding of Composite pheochromocytoma-ganglioneuroma: Successful management after emergent appendectomy and review of the literature..  World Journal of Endocrine surgery .  2011. 3(1):34-44.

Lal G, Clark  O.  Management of Differentiated Thyroid cancers – Updated guidelines from the American Thyroid Association.  2010 December. 

Lal G, Gardner  D, Greenspan  F, Clark  O.  Endocrine Surgery.  McGraw-Hill Companies.  2010. 

Lal G, Fairchild  , Howe  J, Weigel  R, Sugg  S, Menda  Y.  PET-CT for recurrent or persistent differentiated thyroid cancer – Is there added utility beyond conventional imaging? .  Surgery.  2010. 148(6):1082-9.

Lal G, Weigel  , Fang  S, Guidroz  J, O’Malley  , Sugg  , Howe  J.  Expansion of a cell population expressing Stem cell markers in parathyroid glands from patients with Hyperparathyroidism.  Ann Surg.  2010 January. 251(1):107-13.

Lal G, Nowell  A, Liao  J, Sugg  , Weigel  R, Howe  J.  Determinants of survival in patients with calciphylaxis – a multivariate analysis.  Surgery.  2009 December. 146(6):1028-34.

Lal G, Hashimi  , Smith  B, Zhang  L, Lynch  , Robinson  R, Weigel  .  Extracellular Matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer – a hospital-based cohort study in Iowa.  Ann Surg Oncol ;  2009. 

Lal G, Weigel  R, Howe  J, Sugg  S, Sue O'Dorisio  M, O'Dorisio  T, Calva  D.  When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?.  Ann Surg Oncol ;  2009. 

Lal G, Brunicardi  , Clark  O.  Thyroid, Parathyroid and Adrenal.  McGraw-Hill Companies.  2009. 

Adam  L, Calva-Cerqueira  D, Howe  J, Smith  B, Lal G.  Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism.  World J Surg ;  2008. 

Lal G, Domann  F, Padmanabha  L, Provenzano  M, Fitzgerald  M.  Epigenetic regulation of 14-3-3σ expression by aberrant promoter methylation in thyroid carcinoma.  Cancer Lett ;  2008. 

Lal G, O’Dorisio  T, McDougall  I, Weigel  R, Abeloff  .  Cancer of the Endocrine system.  Elsevier Publications.  2008. 

Lal G, Padmanabha L, Nicholson R, Smith B, Zhang L, Robinson R, O'Dorisio M.  ECM1 expression in malignant thyroid neoplasms: A comparison of real-time PCR with immunohistochemistry.  J Surg Res (epub 2007).  2008. 149(1):62-8.

Lal G.  Large adrenal incidentaloma.  Springer.  2008. 

Lal G, Dawson  , Scott-Conner , Maurice   .  Parathyroidectomy.  Lippincott-Williams and Wilkins.  2008. 

Lal G, Maurice  M, Scott-Conner  , Dawson .  Thyroidectomy.  Lippincott-Williams and Wilkins.  2008. 

Lal G, Padmanabha L, Nicholson R, Smith B, Zhang L, Robinson R, O’Dorisio M.  ECM1 expression in malignant thyroid neoplasms: A comparison of real-time PCR with immunohistochemistry.  J Surg Res;  2007. 

Calva-Cerqueira D, Smith B, Hostetler M, Lal G, Menda Y, O'Dorisio T, Howe J.  Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH.  J Am Coll Surg.  2007 October. 205(4 Suppl):S38-44.

Lal G, Clark O.  Basic concepts of parathyroid surgery.  Avrupa publishers (Turkey).  2007. 

Lal G, Gardner  , Clark  O, Greenspan  .  Endocrine Surgery.  McGraw-Hill Companies.  2007. 

Howe J, Larsen-Haidle J, Lal G, Bair J, Song C, Pechman B, Lynch H.  ENG Mutations in SMAD4/BMPR1A Mutation Negative Patients with Juvenile Polyposis.  Clinical Genetics.  2007. 71:91-92.

Lal G, Clark O.  Parathyroidectomy -- The bilateral approach.  Avrupa publishers (Turkey).  2007. 

Kim W, Bartel T, Juweid M, Lal G, Graham M.  Renal cyst uptake following I-131 treatment for thyroid cancer.  Thyroid.  2006 December. 16(12):1315-6.

Lal G, Padmanabha L, Nicholson R, Smith B, Howe J, O'Dorisio M, Domann F.  RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinomas.  Cancer.  2006 December. 107(12):2752-9.

Lal G, Ituarte P, Kebebew E, Siperstein A, Duh Q, Clark O.  Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease?.  Thyroid.  2005 June. 15(6):569-74.

Lal G, Clark O.  Diagnosis of primary hyperparathyroidism and indications for surgery.  Elsevier/Saunders.  2005. 

Lal G, Clark O.  Thyroiditis.  Elsevier/Saunders.  2005. 

Lal G, Clark O.  Thyroid, Parathyroid and Adrenal.  McGraw-Hill Companies.  2004. 

Haciyanli M, Lal G, Morita E, Duh Q, Kebebew E, Clark O.  Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.  J Am Coll Surg.  2003 November. 197(5):739-46.

Lal G, Clark O.  Primary hyperparathyroidism -- Controversies in surgical management.  Trends Endocrinol Metab.  2003 November. 14(9):417-22.

Lal G, Duh Q.  Laparoscopic Adrenalectomy -- Indications and Technique.  Surg Oncol.  2003 August. 12(2):105-23.

Lal G, Brennan T, Hambleton J, Clark O.  Coagulopathy, marantic endocarditis and cerebrovascular accidents as paraneoplastic features in Medullary thyroid cancer.  Thyroid.  2003 June. 13(6):601-5.

Clark O, Lal G.  Novel method for control of mediastinal bleeding during thyroidectomy for substernal goiter.  J Am Coll Surg.  2003 May. 196(5):818-20.

Lal G, Clark O.  Endocrine Surgery.  McGraw-Hill Companies.  2003. 

Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis A, Lal G, Brunet J, Foulkes W, Narod S.  Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas.  Int J Cancer.  2002 February. 97(6):807-10.

Lal G, Gallinger S.  Genetics of pancreatic cancer -- What are the risks?.  The Canadian Journal of CME.  2001 November. 13(11):191-209.

Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans J, Gallinger S.  Suppression of intestinal polyps in Msh2 deficient and non-Msh2 deficient Min mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.  Cancer Res 15.  2001 August. 61(16):6131-6.

Lal G, Gallinger S.  Familial adenomatous polyposis.  Semin Surg Oncol.  2000 June. 18(4):314-23.

Liu G, Ghadirian P, Vesprini D, Hamel N, Paradis A, Lal G, Gallinger S, Narod S, Foulkes W.  Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic anenocarcinoma.  Br J Cancer.  2000 May. 82(10):1646-9.

Lal G, Liu L, Hogg D, Lassam N, Redston M, Gallinger S.  Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.  Genes Chromosomes Cancer.  2000 April. 27(4):358-61.

Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod S, Redston M, Gallinger S.  Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germline p16, BRCA1 and BRCA2 mutations.  Cancer Res 15.  2000. 60(2):409-16.

Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M.  Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.  Am J Hum Genet.  1999. 64(2):378-84.

Carr M, Jamieson C, Lal G.  Blue Rubber Bleb Nevus Syndrome.  Cdn J Surg.  1996. 39(1):59-62.

Lal G, Carr M, Jamieson C.  Pilonidal Sinus Disease: A Review.  UTMJ.  1994. 72(1):26-32.

Lal G, Gomez Contreras P, Kulak M, Woodfield G, Bair T, Domann F, Weigel R.  Human melanoma cells over-express Extracellular Matrix 1 (ECM1) which is regulated by TFAP2C.  PLOS one. 

Lal G, Khullar  .  Hyperthyroidism, thyroiditis and non-toxic goiter. 

Bhama A, Lal G.  Neck dissection.  Lippincott-Williams and Wilkins. 

Lal G.  Parathyroidectomy .  Lippincott-Williams and Wilkins. 

Bhama A, Smith R, Robinson R, Weigel R, Sugg S, Howe J, Lal G.  Preoperative Evaluation of Thyroglossal Duct Cysts: Children versus Adults – Is there a Difference?.  Am J Surg. 

Bhama A, Lal G.  Thyroidectomy. 

Lal G, Bhama  A.  Thyroidectomy.  An Expositive Atlas. 

Date Last Modified: 06/06/2016 - 13:17:48